Feb 2, Pre-OBIO Investment Summit Panel on Accelerating Market Entry to Increase the ROI for Scaling Companies

[CESO]

Hello CESO list serve members.  I am forwarding this event announcement from OBIO in case some of you are interested in attending.

Regards,

Peter Austin

We are reaching out to invite you to share with your network this upcoming OBIO event, Accelerating Market Entry to Increase the ROI for Scaling Companies, February 2.

This pre-Summit panel discussion will kick-off the 2021 OBIO Investment Summit. Register today.

Hear how health organizations acting as early adopters and champions are supporting the clinical and business success of, and de-risking investment in, scaling health technology companies in Canada. The OBIO Early Adopter Health Network (EAHN) is eliminating systemic barriers and accelerating technology evaluation, catalyzing market adoption of Canadian technologies globally. This panel of industry and health organization leaders will explore the opportunity companies have in Canada to take advantage of accelerated market entry.

Panelists:

• Jung-Kay Chiu, Partner, Norton Rose Fulbright (moderator)
• Rob Bull, VP Finance, Technology and Innovation, Southlake Regional Health Centre
• Anthony de Fazekas, Head of Technology and Innovation, Norton Rose Fulbright
• David Martin, Managing Director and Head, Equity Research, Bloom Burton
• Patrick Myles, CEO, Huron Digital Pathology
• Cameron Piron, President, Synaptive Medical
• Mark Taylor, Director, Technology Development and Commercialization, University Health Network (UHN)

Tuesday, February 2 | 12:00-1:00 pm EST

 

Register now

Sincerely,

David Singh

Manager, Market Readiness

Ontario Bioscience Innovation Organization

100 College Street, Suite 213, Toronto ON M5G 1L5

416-848-6839 x112  I  david...@obio.ca  

www.OBIO.ca | @OBIOscience | LinkedIn.ca

 

Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this message is not permitted and may be unlawful.